1. The neurontin legacy-marketing through misinformation and manipulation;Landefeld;N Engl J Med,2009
2. Narrative review: the promotion of gabapentin: an analysis of internal industry documents;Steinman;Ann Intern Med,2006
3. Pringle E. Medtronic's medical device troubles far from over, 2006. Available from: http://www.lawyerandsettlements.com/articles/00251/medtronics_legal.html.
4. Meier B, Saul S. Marketing of Vioxx: how Merck played game of catch-up. New York Times, February 11, 2005; A.1.
5. Conflict of interest with industry and the challenges for surgical education;Schwarze;J Am Coll Surg,2009